-
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
-
Zelluna Completes First GMP Batch of ZI-MA4-1, a Novel TCR-NK Cell Therapy, to Treat Patients in Upcoming First-in-Human Trial
-
Zelluna ASA: Cancellation of subsequent repair offering
-
Zelluna ASA: Cancellation of subsequent repair offering
-
Zelluna ASA – Mandatory notification of trade
-
Zelluna ASA – Mandatory notification of trade
-
Zelluna ASA: New share capital registered
-
Zelluna ASA: New share capital registered
-
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer
-
Zelluna ASA Announces Appointment of Geir Christian Melen as New Chief Financial Officer
